U.S. flag

An official website of the United States government

NM_024675.4(PALB2):c.1383T>A (p.Ser461Arg) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 12, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000781681.2

Allele description [Variation Report for NM_024675.4(PALB2):c.1383T>A (p.Ser461Arg)]

NM_024675.4(PALB2):c.1383T>A (p.Ser461Arg)

Gene:
PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p12.2
Genomic location:
Preferred name:
NM_024675.4(PALB2):c.1383T>A (p.Ser461Arg)
HGVS:
  • NC_000016.10:g.23635163A>T
  • NG_007406.1:g.11195T>A
  • NM_024675.4:c.1383T>AMANE SELECT
  • NP_078951.2:p.Ser461Arg
  • NP_078951.2:p.Ser461Arg
  • LRG_308t1:c.1383T>A
  • LRG_308:g.11195T>A
  • LRG_308p1:p.Ser461Arg
  • NC_000016.9:g.23646484A>T
  • NM_024675.3:c.1383T>A
Protein change:
S461R
Links:
dbSNP: rs768482110
NCBI 1000 Genomes Browser:
rs768482110
Molecular consequence:
  • NM_024675.4:c.1383T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000919923Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Oct 12, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Patterns and functional implications of rare germline variants across 12 cancer types.

Lu C, Xie M, Wendl MC, Wang J, McLellan MD, Leiserson MD, Huang KL, Wyczalkowski MA, Jayasinghe R, Banerjee T, Ning J, Tripathi P, Zhang Q, Niu B, Ye K, Schmidt HK, Fulton RS, McMichael JF, Batra P, Kandoth C, Bharadwaj M, Koboldt DC, et al.

Nat Commun. 2015 Dec 22;6:10086. doi: 10.1038/ncomms10086.

PubMed [citation]
PMID:
26689913
PMCID:
PMC4703835

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000919923.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: The PALB2 c.1383T>A (p.Ser461Arg) variant involves the alteration of a non-conserved nucleotide. 3/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index), however these predictions were not evaluated for functional impact by in vivo/vitro studies. This variant was found in 5/276698 control chromosomes, predominantly observed in the Latino subpopulation at a frequency of 0.0145% (5/34408). This frequency is similar to the estimated maximal expected allele frequency of a pathogenic PALB2 variant (0.01563%), suggesting this is likely a benign polymorphism found primarily in the populations of Latino origin. The variant of interest has been reported in affected individual(s) (Lu 2015), however without evidence for causality (i.e. lack of family history information and co-occurrence data). In addition, one clinical diagnostic laboratory classified this variant as uncertain significance. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024